首页> 外文期刊>International Journal of Clinical Pharmacology Research >Redox balance in patients with down's syndrome before and after dietary supplementation with alpha-lipoic acid and L-cysteine.
【24h】

Redox balance in patients with down's syndrome before and after dietary supplementation with alpha-lipoic acid and L-cysteine.

机译:唐氏综合症患者在饮食中补充α-硫辛酸和L-半胱氨酸前后的氧化还原平衡。

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of the present study was to investigate the possible normalizing effect of antioxidants on certain parameters indicative of oxidative stress in Down's syndrome (DS). The study was performed in pediatric patients with DS with proven redox imbalance, who were advised to take a dietary supplementation composed of alpha-lipoic acid and L-cysteine for several treatment cycles (one treatment cycle = 30 days dietary supplementation plus 30 days wash-out). Serum thiol groups, serum total and septic reactive oxygen species (ROS) and total antioxidant status of serum were determined before and after dietary supplementation, using commercially available kits. In all the evaluable patients (n = 20), after 3.8 +/- 1.1 treatment cycles, thiol group serum concentrations and total antioxidant status of serum significantly increased (p < 0.0001 for both parameters) in comparison with basal values, while serum total and septic ROS significantly decreased (p < 0.0001 for both parameters). On the basis of these results it is impossible to demonstrate the clinical effects of the biochemical normalization obtained in patients with DS after supplying alpha-lipoic acid and L-cysteine. These data suggest that delaying the clinical expression of redox imbalance in patients with DS might be feasible by normalizing their redox balance.
机译:本研究的目的是研究抗氧化剂对指示唐氏综合症(DS)中氧化应激的某些参数的可能的标准化作用。这项研究是在患有氧化还原失衡已证实的DS患儿中进行的,建议他们在几个治疗周期内服用由α-硫辛酸和L-半胱氨酸组成的膳食补充剂(一个治疗周期= 30天的饮食补充+ 30天的冲洗-出来)。使用市售试剂盒测定饮食补充前后的血清硫醇基,血清总和败血活性氧(ROS)以及血清总抗氧化剂状态。在所有可评估的患者(n = 20)中,在3.8 +/- 1.1个治疗周期后,与基础值相比,巯基组血清浓度和血清总抗氧化剂状态显着增加(两个参数均p <0.0001),而血清总和败血性ROS显着降低(两个参数均p <0.0001)。根据这些结果,无法证明在供应α-硫辛酸和L-半胱氨酸后,DS患者的生化正常化的临床效果。这些数据表明,通过使他们的氧化还原平衡正常化,延迟DS患者氧化还原失衡的临床表达可能是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号